Hastings David C insider trades
Hastings David C has filed 15 Form 4s with the SEC that we hold, for Scynexis INC (SCYX) (Director), Arbutus Biopharma Corp (ABUS) (Chief Financial Officer), ETTX (Director) and Trevi Therapeutics, Inc. (TRVI) (Chief Financial Officer). Across all of them we count 0 purchases worth $0 and 2 sales worth $94.9K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 22,183 shares of Arbutus Biopharma Corp worth $72.8K, dated 2025-02-04. The first filing on our record is dated 2022-01-19 and the latest 2026-06-30.
Scynexis INC (SCYX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Arbutus Biopharma Corp (ABUS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-02-02 | S, sale reported on Form 4 | 9,593 | $22.2K | 2024-02-05 |
| 2025-02-04 | S, sale reported on Form 4 | 22,183 | $72.8K | 2025-02-05 |
ETTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Trevi Therapeutics, Inc. (TRVI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1237401) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms